Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results) by Jeemon, Panniyammakal et al.
Distribution of 10-year and lifetime
predicted risk for cardiovascular disease
in the Indian Sentinel Surveillance
Study population (cross-sectional survey
results)
Panniyammakal Jeemon,
1,2,3 Dorairaj Prabhakaran,
1,3,4 Mark D Huffman,
1,5
Lakshmy Ramakrishnan,
6 Shifalika Goenka,
1 K R Thankappan,
7 V Mohan,
8
Prashant P Joshi,
9 B V M Mohan,
10 F Ahmed,
11 Meera Ramanathan,
12 R Ahuja,
13
Vivek Chaturvedi,
14 Donald M Lloyd-Jones,
5 K Srinath Reddy,
3 on behalf of the
Sentinel Surveillance in Industrial Populations Study Group
ABSTRACT
Introduction: Cardiovascular disease (CVD)
prevention guidelines recommend lifetime risk
stratiﬁcation for primary prevention of CVD, but no
such risk stratiﬁcation has been performed in India to
date.
Methods: The authors estimated short-term and
lifetime predicted CVD risk among 10054 disease-free,
adult Indians in the 20e69-year age group who
participated in a nationwide risk factor surveillance
study. The study population was then stratiﬁed into
high short-term ($10% 10-year risk or diabetes), low
short-term (<10%)/high lifetime and low short-term/
low lifetime CVD risk groups.
Results: The mean age (SD) of the study population
(men¼63%) was 40.8610.9 years. High short-term
risk for coronary heart disease was prevalent in more
than one-ﬁfth of the population (23.5%, 95% CI 22.7
to 24.4). Nearly half of individuals with low short-term
predicted risk (48.2%, 95% CI 47.1 to 49.3) had a high
predicted lifetime risk for CVD. While the proportion of
individuals with all optimal risk factors was 15.3%
(95% CI 14.6% to 16.0%), it was 20.6% (95% CI
18.7% to 22.6%) and 8.8% (95% CI 7.7% to 10.5%) in
the highest and lowest educational groups,
respectively.
Conclusion: Approximately one in two men and three
in four women in India had low short-term predicted
risks for CVD in this national study, based on
aggregate risk factor burden. However, two in three
men and one in two women had high lifetime predicted
risks for CVD, highlighting a key limitation of
short-term risk stratiﬁcation.
INTRODUCTION
Cardiovascular disease (CVD) is the leading
cause of death in India, contributing to
nearlyone-thirdofalldeaths.
1Coronaryheart
disease (CHD) deaths, a major contributor to
CVD deaths inIndia, rose from 1.17 million in
1990 to 1.59 million in 2000 and are further
projected to rise to 2.03 million in 2010.
2 Risk
stratiﬁcation and identiﬁcation of individuals
with a high risk for CHD who could poten-
tially beneﬁt from intensive primary preven-
tion efforts are critically important in
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ARTICLE SUMMARY
Article focus
- Lifetime risk of cardiovascular disease (CVD) in
the Indian population.
- Gender differences in lifetime risk of CVD.
- Educational status and lifetime risk of CVD.
Key messages
- Nearly half of individuals with a low short-term
predicted risk had a high predicted lifetime risk
for CVD.
- The proportion of individuals with all optimal risk
factors was 15%.
- A signiﬁcantly lower proportion of individuals in
the lowest educational class had all optimal risk
factors compared with individuals in the higher
educational class.
- Approximately one in two men and three in four
women from working families in India had low
short-term predicted risk for CVD.
Strengths and limitations of this study
- These are the ﬁrst estimates to combine short-
term and lifetime predicted risks for CVD in India.
- Our simple cardiovascular-risk-factor counting
strategy provides a good way of identifying
individuals at high and low lifetime risk for CVD,
but the lifetime CVD risk prediction model has
not been validated or calibrated in India.
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Open Access Researchreducing the burden of CVD in India. Short-term CHD
risk assessment and stratiﬁcation tools have been widely
used for risk stratiﬁcation among asymptomatic individ-
uals who are clinically free of CHD.
3e11 However,
a signiﬁcant proportion of CHD events occur among
individuals with a relatively low short-term (10 year)
predicted CHD risk,
12 as many of them become high-risk
across the lifespan. Lifetime CVD risk estimation, which
measures the cumulative risk of developing the disease
during the remainder of an individual’s lifespan, may
provide a more appropriate assessment on future CVD
risk than short-term (typically 10 year) risk estimates,
especially in younger individuals in whom short-term
risks are low. Therefore, various guidelines now recom-
mend stepwise stratiﬁcation of asymptomatic and disease-
free individuals into high short-term, low short-term/
high lifetime and low short-term/low lifetime CHD risk
groups for targeting primary prevention strategies in all
eligible individuals.
13e16
Short-term CHD risk prediction models discriminate
reasonably well across ethnic groups
17 but need to be
recalibrated based on the differences in age- and sex-
speciﬁc disease incidence rates of the population in
question. Since Indians have been shown to have
a higher risk factor burden at younger ages compared
with Western populations,
18 risk prediction models
developed in Western countries may underestimate
short-term CHD risk. Short-term risk prediction models,
such as the Framingham Risk Score, have been recali-
brated for Indian emigrants to the UK in the ETHRISK
calculator
19 and to a small rural population in India.
20
However, no lifetime risk models have been available for
Indians living in India.
We report here the estimates of lifetime CVD risk
among disease-free, adult Indians who participated in
a nationwide risk factor surveillance study in industrial
settings, using a previously published short-term and
lifetime risk algorithm based on traditional CVD risk
factors (age, sex, total and high-density lipoprotein
cholesterol, tobacco, blood pressure, antihypertensive
treatment, and diabetes).
13 21
METHODS
Study participants
We identiﬁed eligible individuals from the Sentinel
Surveillance study in the Indian industrial Population
(SSIP) database. The details of the SSIP study have been
described previously.
22 Brieﬂy, 10 medium-to-large
industries (deﬁned as industries employing 1500e5000
people) were selected from different sites spread across
India, from both public and private sectors, based on
their willingness to participate in the study and prox-
imity to an academic medical institution. All employees
and their family members between the ages of 20 and
69 years were eligible to be included in the survey. Data
were obtained from randomly selected employees and
their eligible family members (n¼2000 at each centre) at
each participating centre. Further, from this group, we
chose nearly 1000 individuals per centre (800 employees
and their family members) by stratiﬁed random
subsampling for biochemical analysis. The study is
approved by ethic committee/institutional review boards
of all participating academic institutes, and written
informed consent was obtained from all participants. A
total of 19973 (11898 men) individuals consented to
participate in the questionnaire survey and 10543 indi-
viduals for the biochemical analysis in the age group of
20e69 years. Individuals with a past history of CHD,
missing values for age, systolic blood pressure (SBP),
total cholesterol (TC), HDL cholesterol (HDL-c),
plasma glucose (PG), antihypertensive treatment history
and tobacco use were excluded from the analysis. The
ﬁnal database included 10054 individuals.
Socio-demographics, lifestyle habits, medications and
medical history (including the Rose angina question-
naire) were assessed using a structured questionnaire
administered by trained study staff. Standard procedures
and equipments were used to measure body weight and
height. Blood pressure was measured using automated
BP monitoring equipment (Omron MX3, Bannockburn,
Illinois, USA). Two measurements were taken at least
5 min apart before collecting the blood samples and
averaged. Study participants were instructed in advance
not to consume any drinks and tobacco at least 1 h
before attending the screening clinic. A fasting blood
sample was also collected (minimum 8 h fasting) for
biochemical analysis of PG and serum lipids. The central
coordinating laboratory reanalysed 10% of the
biochemical samples and reported less than 5% coefﬁ-
cient of variation between the central coordinating
laboratory results and the individual laboratory results.
Risk factor deﬁnitions
Current tobacco use was deﬁned as the use of any form of
tobacco products (smoking and smokeless form) in the
previous 30 days. Obesity was deﬁned as a body mass
index (BMI) of $30 kg/m
2. Diabetes was deﬁned as
either a fasting PG value of $126 mg/dl
23 or on medi-
cation for diabetes. CHD was deﬁned as physician-
conﬁrmed myocardial infarction or unstable angina or
symptoms suggestive of CHD from the Rose angina
questionnaire. Low high-density cholesterol (HDL-c) was
deﬁnedasanHDL-cof<40 mg/dlformenor<50 mg/dl
for women.
13
Short-term and lifetime risk stratiﬁcation
The 10-year short-term predicted risk for CHD events
(myocardial infarction or coronary death) was estimated
for all participants using the Adult Treatment Panel III
(ATP III) risk-assessment tool.
13 17 A high short-term
predicted risk was deﬁned as a 10-year predicted risk for
a hard CHD event (death, myocardial infarction) of
$10% or diagnosed diabetes.
24 Among individuals with
a low short-term predicted risk, the lifetime predicted
risk for CVD (myocardial infarction, coronary insufﬁ-
ciency, angina, atherothrombotic stroke, intermittent
claudication or CVD death) was estimated using a previ-
ously published algorithm based on the aggregate risk
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21 Subsequently, a secondary
analysis was performed, which included obesity and low
HDL-c as major risk factors.
Statistical analysis
We used summary statistics (proportion, mean and SD)
to describe the data. The study group was divided into
three different risk strata (low short-term and low life-
time risk, low short-term and high lifetime risk, and high
short-term risk) as per the methods described above.
The proportion of individuals in each risk strata was
estimated separately for men and women. The differ-
ences in proportion of individuals within each stratum
were compared across, educational status categories and
locations of industries. Furthermore, using linear
regression models with age as an independent variable,
we estimated the risk factor levels at the age 50 for all
individuals and stratiﬁed the groups into various lifetime
CVD risk categories. We used Statistical Package for
Social Sciences Version 17 for all analyses.
RESULTS
A total of 10054 individuals (men¼6307) were eligible to
be included in this analysis. The mean age (6SD) of the
study population was 40.8610.9 years. The proportions
of tobacco users, participants with hypertension and
diabetes were 26.9%, 26.4% and 9.5%, respectively. The
proportions of individuals with dyslipidaemia were 25.5%
(TC >200 mg/dl) and 53.4% (HDL-c <50 mg/dl in
women and <40 mg/dl in men).
A high short-term risk ($10% 10-year risk or diabetes)
for CHD was prevalent in more than one-ﬁfth of the
population (23.5%, 95% CI 22.7 to 24.4). The propor-
tion of individuals with a high short-term predicted risk
was signiﬁcantly higher in men (31.2, 95% CI 30.1 to
32.4) than in women (10.6, 95% CI 9.6 to 11.6)
(ﬁgure 1). Nearly half of the individuals with a low
(<10%) short-term predicted risk (48.2%, 95% CI 47.1
to 49.3) had a high predicted lifetime risk for CVD based
on the aggregate risk factor burden. Almost one-third
(31.4%, 95% CI 30.2 to 32.5) of men and more than half
(53.5%, 95% CI 51.9 to 55.1) of women were in the
lowest risk stratum of low short-term/low lifetime
predicted risk.
As expected, the mean age, SBP, DBP, BMI, waist
circumference, fasting PG, triglycerides and TC/HDL-c
were lowest in the low short-term/low lifetime risk group
(table 2). The proportions of current tobacco use were
43% and 47% in the low short-term/high lifetime and
high short-term predicted risk groups, respectively.
Table 1 Estimation of lifetime risk for cardiovascular disease (CVD)
CVD risk factors Optimal risk factors Non-optimal risk factors Elevated risk factors Major risk factors*
SBP and DBP (mm Hg) SBP<120
and DBP<80
SBP 120e139
or DBP 80e89
SBP 140e159
or DBP 90e99
SBP$160 or
DBP$100 or treated
AND OR OR OR
Total cholesterol (mg/dl) <180 180e199 200e239 $240 or treated
AND AND AND OR
Diabetes mellitus No No No Yes
AND AND AND OR
Current smoking No No No Yes
Lifetime risk
stratiﬁcation Low predicted lifetime risk High predicted lifetime risk
All optimal risk
factors
$1 risk factors not
optimal
$1 elevated risk
factors
1 major risk
factor
$2 major risk
factors
Lifetime risk refers to risk of all atherosclerotic CVD (myocardial infarction, coronary insufﬁciency, angina, atherothrombotic stroke, intermittent
claudication or CVD death). An individual’s risk stratum is the highest risk stratum for which any of the individual’s risk factors are eligible.
*In the secondary analysis, obesity and low high-density lipoprotein cholesterol were also counted as major risk factors.
DBP, diastolic blood pressure; SBP, systolic blood pressure.
Figure 1 Sample estimates of
risk strata (as per table 1) among
cardiovascular-disease-free,
non-pregnant participants of the
Indian Sentinel Surveillance
Study.
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Lifetime CVD risk stratiﬁcation in the Indian populationHypertension was present in more than half (53.1%) of
the high short-term risk group, in more than one-third
(37.9%) of the low short-term/high lifetime risk group
and in none of the low lifetime risk group. The preva-
lence of dyslipidaemia increased from 12.6% (low short-
term/low lifetime risk) to 24.4% (low short-term/high
lifetime risk) to 48.8% (high short-term risk) across
the three groups. The prevalence of diabetes among
the high short-term risk group was 40.3% but was 0%
(by deﬁnition) in the both the low short-term/low
Table 2 Characteristics of study population
Variables
Low short-term/
low lifetime risk
(N*[3983, 1980, 2003)
Low short-term/
high lifetime risk
(N*[3706, 2358, 1348)
High short-term risk
(N*[2365, 1969, 396)
Age, years; mean (SD) 35.8 (10.4) 39.8 (9.4) 50.6 (7.0)
Men 36.7 (11.0) 39.0 (9.3) 50.8 (6.5)
Women 34.9 (9.8) 41.2 (9.5) 50.0 (9.2)
Systolic blood pressure, mm Hg; mean (SD) 117.0 (10.7) 126.6 (16.3) 136.3 (19.6)
Men 119.5 (9.8) 125.7 (15.0) 135.7 (19.0)
Women 114.6 (11.0) 128.2 (18.2) 139.7 (22.1)
Diastolic blood pressure, mm Hg; mean (SD) 74.0 (8.1) 80.0 (11.5) 83.3 (11.1)
Men 74.5 (7.9) 79.3 (11.2) 83.0 (11.1)
Women 73.5 (8.4) 81.2 (11.9) 84.9 (10.7)
Body mass index, kg/m
2; mean (SD) 23.4 (4.0) 23.7 (4.4) 24.6 (3.8)
Men 23.0 (3.5) 23.2 (3.8) 24.4 (3.5)
Women 23.7 (4.4) 24.5 (5.1) 25.9 (4.9)
Waist circumference, cm; mean (SD) 82.0 (11.4) 83.9 (11.3) 89.4 (10.0)
Men 84.6 (10.4) 85.1 (10.5) 89.9 (9.6)
Women 79.3 (11.7) 81.8 (12.4) 87.0 (11.4)
Plasma glucose, mg/dl; mean (SD) 86.9 (13.0) 89.0 (13.8) 116.2 (46.2)
Men 88.1 (13.1) 89.1 (14.0) 111.9 (41.3)
Women 85.6 (12.8) 88.9 (13.5) 137.6 (61.2)
Total cholesterol, mg/dl; mean (SD) 158.8 (24.9) 184.3 (44.3) 194.1 (42.3)
Men 159.1 (25.3) 178.9 (43.4) 193.0 (41.1)
Women 158.5 (24.5) 193.9 (44.2) 199.6 (47.4)
High-density lipoprotein, mg/dl; mean (SD) 43.1 (10.1) 46.0 (11.0) 39.6 (10.1)
Men 41.6 (9.7) 45.3 (10.9) 39.0 (9.4)
Women 44.6 (10.4) 47.2 (11.1) 42.8 (12.2)
Triglycerides, mg/dl; mean (SD) 108.7 (50.7) 129.7 (71.3) 160.6 (94.4)
Men 118.0 (55.9) 133.5 (73.6) 161.5 (94.8)
Women 99.5 (42.9) 123.0 (66.5) 156.1 (92.1)
Total cholesterol/high-density lipoprotein;
mean (SD)
3.9 (1.0) 4.2 (1.4) 5.2 (1.7)
Men 4.0 (1.0) 4.1 (1.4) 5.2 (1.6)
Women 3.7 (1.0) 4.3 (1.4) 5.0 (1.9)
Current tobacco use (n, %) 0 1592, 43.0 1114, 47.0
Men 0 1310, 55.6 1054, 53.5
Women 0 282, 20.9 58, 14.6
Diabetes (n, %) 0 0 952, 40.3
Men 0 0 664, 33.7
Women 0 0 288, 72.7
Hypertension (n, %) 0 1403, 37.9 1251, 53.1
Men 0 793, 33.6 994, 50.5
Women 0 610, 45.3 261, 65.9
Dyslipidaemia (n, %) 501, 12.6 904, 24.4 1153, 48.8
Men 294, 14.8 554, 23.5 977, 49.6
Women 207, 10.3 350, 26.0 176, 44.4
Antihypertensive therapy (n, %) 0 298, 8.0 444, 18.8
Men 0 154, 6.5 338, 17.2
Women 0 144, 10.7 106, 26.8
Framingham 10 year risk, % (median
and IQR)
0.8 (0.1e2.9) 3.6 (1.3e6.4) 13.1 (10.7e16.7)
Men 1.8 (0.4e4.8) 4.4 (1.8e7.0) 13.5 (11.1e17.2)
Women 0.2 (0.0e1.4) 2.3 (0.5e4.8) 11.2 (7.0e14.4)
*N for total, men and women.
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groups. The median Framingham 10 year risk score
increased from 0.8% (IQR: 0.1e2.9) in the low short-
term/low lifetime risk group to only 3.6%
(IQR: 1.3e6.4) in the low short-term/high lifetime risk
group.
The proportion of individuals with all optimal risk
factor levels was 15.3% (95% CI 14.6% to 16.0%). In the
youngest age group (20e29 years), nearly one-third
(32.6%, 95% CI 30.6 to 34.7) of participants had all
optimal risk factors (table 3), while only 4.8% (95% CI
3.9% to 5.6%) of participants from the oldest age group
Table 3 Distribution of combined 10-year coronary heart disease and lifetime cardiovascular disease predicted risk strata in
the Indian Industrial Sentinel Surveillance data
Variables
Low short-term/low
lifetime risk Low short-term/high lifetime risk
High short-
term risk p Value All optimal
‡1 not
optimal ‡1 elevated 1 major ‡2 major
Total (n, %) 1538, 15.3 2445, 24.3 1623, 16.1 1965, 19.5 118, 1.2 2365, 23.5
Age group (total)
20e29 (n, %) 653, 32.6 681, 34.0 251, 12.5 387, 19.3 14, <1.0 17, <1.0
30e39 (n, %) 425, 19.7 643, 29.8 384, 17.8 577, 26.7 25, 1.2 105, 4.9
40e49 (n, %) 347, 9.8 805, 22.8 721, 20.4 732, 20.7 54, 1.5 871, 24.7
50e59 (n, %) 106, 5.3 299, 14.3 250, 12.0 249, 11.9 21, 1.0 1159, 55.6
60e69 (n, %) 7, 2.5 17, 6.1 17, 6.1 20, 7.2 4, 1.4 213, 76.6
Age group (men)
20e29 (n, %) 251, 22.1 408, 35.9 137, 12.0 319, 28.0 13, 1.1 10, <1.0
30e39 (n, %) 145, 12.4 300, 25.6 185, 15.8 453, 38.7 21, 1.8 66, 5.6
40e49 (n, %) 156, 7.0 420, 18.9 349, 15.8 533, 24.1 36, 1.6 720, 32.5
50e59 (n, %) 76, 4.7 217, 13.3 142, 8.7 155, 9.5 7, <1.0 1033, 63.4
60e69 (n, %) 4, 2.6 3, 1.0 1, <1.0 7, 4.5 0, 0 140, 90.3
Age group (women)
20e29 (n, %) 402, 46.4 273, 31.6 114, 13.2 68, 7.9 1, <1.0 7, <1.0
30e39 (n, %) 280, 28.3 343, 34.7 199, 20.1 124, 12.5 4, <1.0 39, 3.9
40e49 (n, %) 191, 14.5 385, 29.2 372, 28.2 199, 15.1 18, 1.4 151, 11.5
50e59 (n, %) 30, 6.6 82, 18.0 108, 23.7 94, 20.7 14, 3.0 126, 27.7
60e69 (n, %) 3, 2.4 14, 11.4 16, 13.0 13, 10.6 4, 3.2 73, 59.3
Location (total)
Highly urban (n, %) 836, 14.3 1454, 24.8 1063, 18.1 838, 14.2 48, <1.0 1620, 27.6 <0.001*yzx
Urban (n, %) 460, 18.7 686, 28.0 392, 16.0 360, 14.7 20, <1.0 536, 21.8
Periurban (n, %) 242, 13.9 305, 17.5 168, 9.6 767, 44.1 50, 2.9 209, 12.0
Location (men)
Highly urban (n, %) 361, 9.4 839, 21.8 557, 14.5 655, 17.0 35, <0.1 1408, 36.5 <0.001*yzx
Urban (n, %) 171, 13.1 320, 24.3 155, 11.8 261, 20.0 16, 1.2 392, 29.8
Periurban (n, %) 100, 8.8 189, 16.6 102, 9.0 551, 48.0 26, 2.3 169, 14.7
Location (women)
Highly urban (n, %) 475, 23.7 615, 30.7 506, 25.2 183, 9.0 13, <1.0 212, 10.6 <0.001*yzx
Urban (n, %) 289, 25.4 366, 32.1 237, 20.8 99, 9.0 4, <1.0 144, 12.6
Periurban (n, %) 142, 23.5 116, 19.2 66, 10.9 216, 36.0 24, 3.9 40, 6.6
Education (total)
ESI (n, %) 336, 20.6 513, 31.3 368, 22.5 358, 21.9 59, 3.6 248, 15.2 <0.001*yzx{
ESII (n, %) 423, 18.4 668, 29.1 505, 22.1 564, 24.6 129, 5.6 432, 18.9
ESIII (n, %) 636, 14.2 1090, 24.4 807, 18.1 1533, 34.3 401, 9.0 1260, 28.2
ESIV (n, %) 146, 8.8 269, 16.2 203, 12.2 851, 51.2 193, 11.6 425, 25.6
Education (men)
ESI (n, %) 144, 13.7 175, 30.1 192, 18.2 170, 16.1 9, <1.0 219, 20.8 <0.001*yzx{
ESII (n, %) 161, 11.4 282, 32.3 211, 14.9 277, 19.5 16, <1.0 388, 27.4
ESIII (n, %) 301, 9.6 441, 33.5 389, 12.4 697, 22.1 35, 1.1 1117, 35.4
ESIV (n, %) 26, 3.8 199, 20.4 22, 3.2 323, 47.2 17, 2.5 245, 35.8
Education (women)
ESI (n, %) 192, 33.0 175, 30.1 137, 23.6 46, 7.9 1, <1.0 29, <1.0 <0.001*yzx{
ESII (n, %) 261, 29.9 282, 32.3 228, 26.1 55, 6.3 2, <1.0 44, <1.0
ESIII (n, %) 331, 25.2 441, 33.5 288, 21.9 106, 8.1 7, <1.0 143, 10.9
ESIV (n, %) 120, 12.3 199, 20.4 156, 16.0 291, 29.8 31, <3.2 180, 18.4
p Values are for the comparison across the rows (*$1 not optimal risk factors; y$1 elevated risk factors; z1 major risk factor; xhigh short-term
risk; {all optimal risk factors) and are adjusted for age.
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Lifetime CVD risk stratiﬁcation in the Indian population($50 years) had this optimal proﬁle. While the preva-
lence of the high short-term risk group was 50.0% (95%
CI 47.9% to 52.0%) in the age group of $50 years, <1%
of participants from the youngest age group had a high
short-term risk.
The proportions of individual with a high short-term
risk were 27.6% (95% CI 26.5% to 28.8%), 21.8% (95%
CI 20.2% to 23.5%) and 12% (95% CI 10.5% to 13.5%)
in highly urban, urban and periurban locations, respec-
tively. While the proportion of individuals with all
optimal risk factors was 20.6% (95% CI 18.7% to 22.6%)
in the highest educational group (graduate school
education), only 8.8% (95% CI 7.7% to 10.5%) of
participants from the lowest educational group (up
to primary school education) had this optimal risk
proﬁle (p<0.001). Similarly, the proportion of individ-
uals with high-short term risk was 15.2% (95% CI 13.5%
to 17.0%) in the highest education group and 25.6%
(95%CI24.1% to 28.3%) inthelowesteducationalgroup
(p<0.001).
In the secondary analysis with obesity and low HDL-c
included as major risk factors, the overall proportion of
individuals with high short-term risk was 23.5% (95% CI
22.7% to 24.4%). It was signiﬁcantly lower in women
(10.6%, 95% CI 9.6% to 11.6%) than in men (31.2%,
95% CI 30.1% to 32.4%). While the overall proportion
of low short-term/low lifetime risk was 32.6% (95% CI
31.6% to 33.5%), it was 37.3% (95% CI 36.1% to 38.5%)
in men but only 24.5% (95% CI 23.2% to 25.9%) in
women (ﬁgure 2).
In the ﬁnal analysis with estimated risk factors for all
individuals at age 50 years, the proportions of individuals
in the low short-term/low lifetime and low short-term
high lifetime risk strata were 30% (95% CI 29.0% to
30.8%) and 47% (95% CI 45.6% to 47.6%), respectively
(ﬁgure 3).
DISCUSSION
Wehavereported the distributionofshort-term CHD and
lifetime CVD predicted risks using data from a national
cardiovascular risk factor surveillance study in India. To
the best of our knowledge, lifetime risk stratiﬁcation
algorithms have not been used in the Indian population
for risk categorisation. The vast majority (85%) of adults
in this population have $1 non-optimal risk factors.
Althoughmorethanthree-fourthsofthestudypopulation
are at low (<10%) short-term predicted risk for a CHD
event, nearly half are at high lifetime predicted risk
for CVD based on their current aggregate risk factor
burden.
While the absolute short-term and lifetime risk esti-
mates presented here have not been calibrated to an
Indian population, the nearly universal risk relationships
between risk factors and incident CHD
18 suggest that
this risk-factor counting algorithm provides a reliable
discrimination between individuals at lower and higher
short-term and lifetime risk. These data provide best
estimates of short-term and lifetime risk stratiﬁcation in
the absence of underlying CHD and CVD incidence data
based on hard end-points.
Figure 2 Distribution of combined 10-year cardiovascular
disease (CVD) and lifetime CVD predicted risk strata in the
CVD-free, non-pregnant participants in the Indian Sentinel
Surveillance Study with obesity and low HDL included as major
risk factors.
Figure 3 Sample estimates of risk strata (as per table 1)
among cardiovascular-disease-free, non-pregnant participants
of the Indian Sentinel Surveillance Study using estimated risk-
factor levels at age 50 years.
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Lifetime CVD risk stratiﬁcation in the Indian populationIn the US National Health and Nutrition Examina-
tion Surveys (2003e2004 or 2005e2006 surveys), the
same lifetime risk-stratiﬁcation algorithm classiﬁes
a lower proportion of individuals into the all-optimal
risk factor proﬁle,
24 compared with our sample (11% in
the USA vs 15% in India). This difference appears to be
due, at least in part, to a higher proportion of older
individuals (60e79 years) in the National Health and
Nutrition Examination Survey sample. Nevertheless,
maintenance of this proﬁle into middle age has been
associated with substantially lower rates of CVD across
the lifespan,
21 greater longevity,
21 25 better quality of life
at older ages,
26 compression of morbidity and reduced
medical expenditures later in life.
27 While more than
half (55.5%) of the US adult population is classiﬁed as
low short-term/high lifetime risk group,
24 this risk
proﬁle was seen in 37% of our sample. This group may
be a key target for primary CVD preventive efforts,
particularly in light of the burgeoning CVD epidemic in
India.
Risks by gender and age group
The lifetime risk algorithm identiﬁed signiﬁcant
proportions of women and younger adults (<40 years)
to be at low short-term/high lifetime risk category. Given
the limitations of the ATP III risk-assessment tool for risk
prediction and underestimation of CHD risk in women
and young adults,
28 29 the lifetime risk tool may provide
important adjunctive information in this population.
Although the inclusion of obesity and low HDL-c does
not substantially increase the prevalence of men with low
short-term/high lifetime risk, these factors signiﬁcantly
increase the proportion of women with low short-term/
high lifetime risk. Therefore, the addition of BMI and
HDL to short-term and lifetime risk prediction for
Indian women may help to identify more women with
elevated CVD risk who may beneﬁt from targeted
primary preventive efforts.
Although women and younger adults have a signiﬁ-
cantly lower risk for CVD in the present study, they are at
signiﬁcantly greater risk for future CVD events during
the life course in comparison with those with a low life-
time predicted risk. Communicating these additional
messages to this target community may help to motivate
high-lifetime-risk individuals to adopt a healthy lifestyle
so as to achieve a desirable risk proﬁle.
Risks by urbanicity and socio-economic status
A growing vulnerability of individuals in urban locations
and in the lower socio-economic status (SES) to CHD
has been recognised in the Indian population.
30e32
When we stratiﬁed the risk groups according to industry
location, a signiﬁcantly higher proportion of individuals
in the highly urban region were found to have a high
short-term risk for CHD than individuals in the peri-
urban region. The implications of these ﬁndings are
enormous in a country like India where the number of
population residing in urban areas has increased from
26 million in 1901 to 288 million in 2001.
33
Among several measures of SES, educational attain-
ment has been reported to be a valid and easily
measurable indicator of SES
34 that is also considered
suitable for social ranking across many populations at
different stages of development. In our population,
a signiﬁcantly higher proportion of individuals in the
lowest educational class reported a high short-term
CHD risk in comparison with the highest educational
class, as previously reported.
30 Similarly, the proportion
of individuals with a high lifetime risk was signiﬁcantly
higher in the low educational class in comparison with
the highest educational class. The social gradient
observed in CHD risk in India demonstrates the
importance of targeting those with lower levels of
education when planning CVD-risk-factor-prevention
programmes.
Strengths/limitations
These are the ﬁrst data from India to evaluate the
proportion of individuals with low and high predicted
lifetime risks for CVD. Lifetime risk stratiﬁcation may
be more relevant to real-world scenarios than
KaplaneMeier estimates, which tend to overestimate
risk, since lifetime risk modelling accounts for
competing causes of death. Lifetime risks may also
improve risk communication with patients.
Our analysis has several limitations. First, both short-
term and lifetime risk-stratiﬁcation algorithms have not
been validated and calibrated in the Indian population.
Traditional risk-stratiﬁcation algorithms, such as the
Framingham Risk Score, tend to overestimate risk in
low-risk populations and underestimate it in high-risk
populations.
35 36 However, India does not currently
have any cohort (longitudinal) data with hard CVD
endpoints to validate these models. The strength of
a simple risk-factor counting strategy to stratify indi-
viduals into high and low lifetime risk takes advantage
of the similar relative risks associated with incident
CHD events, as demonstrated in the INTERHEART
study.
18 Second, the short-term model used predicts
hard CHD events (death, myocardial infarction),
whereas the lifetime-risk model used predicts total CVD
events. Nonetheless, total CVD may be more clinically
relevant than restricting risk prediction to CHD-only
events. Finally, the concept of lifetime risk is taken from
risk-factor data among participants of the Framingham
study when they reached the age of 50 years.
21 To
account for this difference, we have estimated the
expected risk-factor levels in all participants at 50 years
of age and analysed the lifetime CVD risk. However, the
risk-factoredisease lifetime risk relationship is further
strengthened with the evaluation of markers of
preclinical atherosclerosis, especially in younger indi-
viduals. For example, younger individuals with higher
risk-factor burdens (the low short-term/high lifetime
risk group) have a thicker carotid intima media thick-
ness and higher coronary calcium scores than individ-
uals with lower risk-factor burdens (low short-term/low
lifetime risk group).
37
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Lifetime CVD risk stratiﬁcation in the Indian populationCONCLUSION
In conclusion, these are the ﬁrst estimates to combine
short-term and lifetime predicted risks for CVD in India.
Approximately one in two men and three in four women
in this study have a low short-term risk, but two in three
men and one in two women have a high lifetime risk for
CVD, highlighting a key limitation of short-term risk
stratiﬁcation. Only 15% of participants had all optimal
cardiovascular risk factors, a pattern associated with
healthy longevity. A signiﬁcantly lower proportion of
individuals in the lowest educational class had all
optimal risk factors compared with individuals in the
higher educational class. We believe that these data
provide strong evidence for broad preventive measures
to combat the CVD epidemic in India, which appears
likely to grow further without such measures.
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